Amanda Perdue
Family · Pensacola, FLNPI 1710621768
Payments from drug & device makers
Across 320 payments — averaging $16.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$830
- Pfizer$706
- AbbVie$557
- Axsome Therapeutics, Inc.$412
- AstraZeneca$327
- Sumitomo Pharma America, Inc.$321
- plus $2K from 31 others
What the payments were for
- Food & beverage$5,222100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 61 | $830 |
| Pfizer | 40 | $706 |
| AbbVie | 47 | $557 |
| Axsome Therapeutics, Inc. | 21 | $412 |
| AstraZeneca | 16 | $327 |
| Sumitomo Pharma America, Inc. | 17 | $321 |
| Bayer | 19 | $307 |
| Boehringer Ingelheim | 11 | $236 |
| Lundbeck LLC | 10 | $192 |
| GSK | 12 | $181 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $165 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $123 |
| Exact Sciences | 6 | $96 |
| Otsuka America Pharmaceutical, Inc. | 5 | $94 |
| Lilly USA, LLC | 4 | $73 |
| Seqirus USA Inc | 2 | $54 |
| Novartis | 3 | $53 |
| Teva Pharmaceuticals USA, Inc. | 2 | $49 |
| Phathom Pharmaceuticals, Inc. | 5 | $45 |
| Dexcom, Inc. | 2 | $44 |
| Ardelyx, Inc. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $34 |
| Sanofi-aventis U.S. LLC | 2 | $33 |
| Merck | 2 | $31 |
| Kowa Pharmaceuticals America, Inc. | 2 | $26 |
| Neuronetics, Inc. | 1 | $22 |
| Tris Pharma Inc | 1 | $21 |
| Shield Therapeutics Inc | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Bausch Health US, LLC | 1 | $16 |
| Amgen | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Ironshore Pharmaceuticals Inc. | 1 | $14 |
| Verona Pharma, Inc. | 1 | $14 |
| Corcept Therapeutics | 1 | $14 |
| Impel Pharmaceuticals Inc. | 1 | $14 |
| Neos Therapeutics, LP | 1 | $13 |
How this compares
$5,222 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Other family in Pensacola
- Brittany PerezPensacola$130K
- Mary AanestadPensacola$54K
- Raymond HalsteadPensacola$50K
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.